UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Virios Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
92829J104 |
December 31 , 2022 |
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 92829J104 | ||||||
(1) | Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)
William L. Pridgen, M.D.
| |||||
(2) | Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) | |||||
(3) | SEC Use Only
| |||||
(4) | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With | (5) | Sole Voting Power
753,819 | ||||
(6) | Shared Voting Power
None | |||||
(7) | Sole Dispositive Power
753,819 | |||||
(8) | Shared Dispositive Power
None | |||||
(9) | Aggregate Amount Beneficially Owned by Each Reporting Person
753,819 | |||||
(10) | Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]
(See Instructions) | |||||
(11) | Percent of Class Represented by Amount in Row (9)
4.1% | |||||
(12) | Type of Reporting Person (See Instructions)
IN |
Alpharetta, Georgia, 30009
Alpharetta, GA 30009
SIGNATURES |
By: | /s/ William L. Pridgen |
Name: William L. Pridgen |